Free tool
FAERS Monitor: Paxil
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020031 or its brand name (Paxil, Paroxetine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
54,135
Serious
33,774
62% of reports
Hospitalization
14,580
Death reported
3,560
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug withdrawal syndrome5,459
- nausea4,157
- drug ineffective3,844
- dizziness3,820
- anxiety3,794
- fatigue3,606
- headache3,242
- depression3,143
- drug exposure during pregnancy2,902
- insomnia2,645
- diarrhoea2,401
- weight increased2,350
- suicidal ideation2,348
- pain2,149
- vomiting2,106
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 5,814 |
| 2005 | 5,231 |
| 2006 | 4,161 |
| 2007 | 2,391 |
| 2008 | 2,508 |
| 2009 | 2,432 |
| 2010 | 2,821 |
| 2011 | 2,916 |
| 2012 | 2,742 |
| 2013 | 1,639 |
| 2014 | 1,702 |
| 2015 | 3,347 |
| 2016 | 3,009 |
| 2017 | 1,872 |
| 2018 | 1,636 |
| 2019 | 1,678 |
| 2020 | 1,452 |
| 2021 | 1,317 |
| 2022 | 1,262 |
| 2023 | 1,151 |
| 2024 | 1,179 |
| 2025 | 1,076 |
| 2026 | 793 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,000,024 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug exposure during pregnancySignal | 2,902 | 36.2 | 34.8 | 90,851 |
| drug withdrawal syndromeSignal | 5,459 | 25.7 | 25.0 | 122,059 |
| suicidal ideationSignal | 2,348 | 10.2 | 9.8 | 19,062 |
| depressionSignal | 3,143 | 5.4 | 5.2 | 11,315 |
| anxietySignal | 3,794 | 5.2 | 5.1 | 13,001 |
| weight increasedSignal | 2,350 | 4.1 | 3.9 | 5,528 |
| insomniaSignal | 2,645 | 3.9 | 3.7 | 5,684 |
| dizzinessSignal | 3,820 | 3.0 | 2.9 | 5,144 |
| nauseaSignal | 4,157 | 2.0 | 2.0 | 2,297 |
| headacheSignal | 3,242 | 2.0 | 1.9 | 1,697 |
| fatigue | 3,606 | 1.8 | 1.7 | 1,333 |
| vomiting | 2,106 | 1.7 | 1.7 | 679 |
| diarrhoea | 2,401 | 1.4 | 1.4 | 340 |
| pain | 2,149 | 1.4 | 1.3 | 210 |
| drug ineffective | 3,844 | 1.1 | 1.1 | 64 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.